Global Gene Silencing Market Growth (Status and Outlook) 2023-2029

Global Gene Silencing Market Growth (Status and Outlook) 2023-2029

Gene silencing is the regulation of gene expression in a cell to prevent the expression of a certain gene. Gene silencing can occur during either transcription or translation and is often used in research.In particular, methods used to silence genes are being increasingly used to produce therapeutics to combat cancer and diseases, such as infectious diseases and neurodegenerative disorders.

LPI (LP Information)' newest research report, the “Gene Silencing Industry Forecast” looks at past sales and reviews total world Gene Silencing sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene Silencing sales for 2023 through 2029. With Gene Silencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene Silencing industry.

This Insight Report provides a comprehensive analysis of the global Gene Silencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene Silencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene Silencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene Silencing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene Silencing.

The global Gene Silencing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Gene Silencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Gene Silencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Gene Silencing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Gene Silencing players cover Alnylam Pharmaceuticals, Benitec Biopharma, Arrowhead Pharmaceuticals, Merck Group, Eli Lilly (Dicerna Pharmaceuticals), Monsanto (Bayer AG), RXi Pharmaceuticals, Silence Therapeutics plc and Idera Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Gene Silencing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Transcriptional
Post-transcriptional
Meiotic

Segmentation by application
Cancer Treatment
Neurological Diseases Treatment
Scar Treatment
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Alnylam Pharmaceuticals
Benitec Biopharma
Arrowhead Pharmaceuticals
Merck Group
Eli Lilly (Dicerna Pharmaceuticals)
Monsanto (Bayer AG)
RXi Pharmaceuticals
Silence Therapeutics plc
Idera Pharmaceuticals

Please note: The report will take approximately 2 business days to prepare and deliver.